XML 52 R35.htm IDEA: XBRL DOCUMENT
v3.19.1

Organization and Description of Business (Narrative) (Details) | Dec. 29, 2017 shares | Dec. 28, 2017 $ / shares | Dec. 31, 2018 $ / shares shares | Dec. 31, 2017 $ / shares shares
--- | --- | --- | --- | ---
Schedule Of Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Common stock, par value (usd per share) |  |  | $ 0.0001 | $ 0.0001
Common stock, shares outstanding (in shares) | shares | 5,766,891 |  | 22,026,476 | 5,766,891
Galena Biopharma, Inc |  |  |  |
Schedule Of Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Reverse stock split ratio |  | 0.0333 |  |
Common stock, par value (usd per share) |  | $ 0.0001 |  |
Private SELLAS Security Holders |  |  |  |
Schedule Of Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Common stock ownership percentage | 67.50% |  |  |
Private SELLAS Security Holders | Galena Biopharma, Inc |  |  |  |
Schedule Of Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Common stock conversion ratio | 43.9972 |  |  |
Pre-Merger Securityholders |  |  |  |
Schedule Of Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Common stock ownership percentage | 32.50% |  |  |

X
- Definition Common Stock Conversion Ratio + References No definition available. + Details
Name: | gale_CommonStockConversionRatio
Namespace Prefix: | gale_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage Of Fully Diluted Share Capital Owned + References No definition available. + Details
Name: | gale_PercentageOfFullyDilutedShareCapitalOwned
Namespace Prefix: | gale_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Schedule Of Summary Of Significant Accounting Policies [Line Items] + References No definition available. + Details
Name: | gale_ScheduleOfSummaryOfSignificantAccountingPoliciesLineItems
Namespace Prefix: | gale_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB TOPIC 4.C) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770 + Details
Name: | us-gaap_StockholdersEquityNoteStockSplitConversionRatio1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=gale_GalenaBiopharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=gale_PrivateSELLASSecurityHoldersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=gale_PreMergerSecurityholdersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |